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Abstract: The reactivity of particle surfaces can be used as a criterion to group nanoforms (NFs)
based on similar potential hazard. Since NFs may partially or completely dissolve over the duration
of the assays, with the ions themselves inducing a response, reactivity assays commonly measure the
additive reactivity of the particles and ions combined. Here, we determine the concentration of ions
released over the course of particle testing, and determine the relative contributions of the released
ions to the total reactivity measured. We differentiate three classes of reactivity, defined as being (A)
dominated by particles, (B) additive of particles and ions, or (C) dominated by ions. We provide
examples for each class by analyzing the NF reactivity of Fe2O3, ZnO, CuO, Ag using the ferric
reduction ability of serum (FRAS) assay. Furthermore, another two reactivity tests were performed:
Dichlorodihydrofluorescin diacetate (DCFH2-DA) assay and electron paramagnetic resonance (EPR)
spectroscopy. We compare assays and demonstrate that the dose-response may be almost entirely
assigned to ions in one assay (CuO in DCFH2-DA), but to particles in others (CuO in EPR and FRAS).
When considering this data, we conclude that one cannot specify the contribution of ions to NF
toxicity for a certain NF, but only for a certain NF in a specific assay, medium and dose. The extent of
dissolution depends on the buffer used, particle concentration applied, and duration of exposure.
This culminates in the DCFH2-DA, EPR, FRAS assays being performed under different ion-to-particle
ratios, and differing in their sensitivity towards reactions induced by either ions or particles. If applied
for grouping, read-across, or other concepts based on the similarity of partially soluble NFs, results on
reactivity should only be compared if measured by the same assay, incubation time, and dose range.
Keywords: nanoform; grouping; nanoform dissolution; reactivity assay; reactivity class;
dissolution product
1. Introduction
There is already a high tonnage of nanoforms (NFs) commercially available, including fillers and
pigments [1], with more under development, with applications ranging from electronics, coatings,
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clothing, food packaging, construction materials, and cosmetics [2]. Despite the need to register
NFs to REACH from 2020 [3], the debate on which parameters are most appropriate for assessing
the NF hazard to biological systems is still ongoing. Due to the large variety of current and future
NFs, a grouping approach of NFs would be beneficial to avoid case-by-case risk assessment and to
predict their adverse effects without animal testing. Most scientific frameworks of grouping consider
surface-induced reactivity as a key property to rationalize and compare the toxicity of NFs [4–10].
Recently, the European Chemicals Agency (ECHA) published the registration and the grouping of NFs,
which recommended “biological (re)activity” as one means of substantiating biological similarities [11].
Such guidance states that the reactivity of NFs can be modulated by each of the four properties that
describe a NF: Size, shape, surface treatment, and specific surface area [12].
NFs can generate reactive oxygen species (ROS) that are sources of oxidative stress and cytotoxicity.
ROS are powerful oxidants that indiscriminately damage cellular targets and can be generated through
interaction with a particle surface by a variety of mechanisms: Fenton reaction, redox cycling, radical
generation [13]. The ability of NFs to generate ROS can be defined as oxidative potential. Several
analytical procedures, so called reactivity assays, are routinely used to determine NF oxidative
potential and quantify the related ROS. Such reactivity assays generally involve the immersion of NFs
in an aqueous medium in the presence of a probe which interacts with the ROS produced, thereby
revealing the oxidative potential of the NFs by spectroscopic, spectrophotometric, or chromatographic
methods [14].
However, some NFs may partially or completely dissolve to the ionic forms during the incubation
time of the assays. In 2018, Gray et al. proposed a framework for grouping two-dimensional NFs
based on their dissolution behavior in media. NF dissolution kinetics and their dissolved products are
used to place NFs in 4 different classes with higher or lower priority for additional nanotoxi-cology
testing [15].
It remains an open question therefore as to whether the measured reactivity derives from the
reactive processes on the particle surface or whether it originates from interactions with dissolved ions.
Especially for ZnO and CuO particles, the debate has been recurring over whether or not the observed
reactivity is due to the ions or due to the remaining particles [6,16]. Grouping of NFs by their “surface
reactivity” or “oxidative potential” is not robust without knowing the main contributor (the particle or
the ions) for ROS generation.
In the simplest approach to assess reactivity of a NF, the characteristics that govern the reactivity
of a suspension of soluble NFs, include chemical composition, diameter, shape, dissolution rate in a
specific medium, reactivity of particle-surface, and reactivity of ions (or other dissolution products).
Additionally, as different measures of reactivity use different protocols, dispersion media, and timing
(from minutes to hours), all of the substance-related and method-related parameters that can influence
the extent of particle dissolution during the assay need to be considered.
Here, we evaluate the oxidative potential of four particles (CuO, ZnO, Fe2O3, Ag) and their free
ions utilizing the highly sensitive ferric reduction ability of serum (FRAS) assay. These particles are
commonly used in a variety of applications ranging from electronic industries and medical devices
to clothing and soil remediation [17]. Due to the expanding number of applications for each of
these materials, there is an increased potential for release into the environment, inducing concern
related to their possible adverse effects. The FRAS assay employs human serum and quantifies the
total antioxidant depletion induced by NF as a measure of their oxidative potential. Considering
additive contributions of particles and ions, we describe a model that differentiates three classes of
reactivity: (A) Dominated by particles, (B) Additive of particles and ions, or (C) Dominated by ions,
and demonstrate the implementation of this model using a pragmatic experimental workflow. Selecting
one NF (CuO), we also compare the relative contributions of particles and ions established by the FRAS
assay with two further well-established acellular assays: The acellular dichlorodihydrofluorescein
diacetate (DCFH2-DA) assay and electron paramagnetic resonance (EPR) spectroscopy with each test
differing greatly in principle and experimental methodology. The DCFH2-DA assay determines the
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oxidation of non-fluorescent molecules into a fluorescent form in presence of ROS, whereas EPR is
a standardized technique to identify and quantify free radicals via spin trap [14]. The aim of the
research performed was to compare the impact of particles and ions on the performance of three
assays for assessing the reactivity of suspensions of NFs. Interestingly, the results reported reveal
differences in the relative contribution of particles and ions to the reactivity measurements, which
may be a result of methodological differences in incubation time, dispersion media, etc. Therefore,
we recommend that care should be taken when assigning the relative contribution of particles and
ions to reactivity measurement and suggest that when conducting reactivity assays for grouping or
read-across purposes, results on reactivity should only be compared if measured by the same assay,
incubation time, and dose range.
2. Materials and Methods
2.1. Materials
Two NFs (CuO and Fe2O3 nano_A) were obtained from industries and two (Ag NM300k and
ZnO NM111) were received from the European Joint Research Center (JRC, Ispra, Italy). The coding
used equals the JRC code. CuO NF was purchased by PlasmaChem (Berlin, Germany). Fe2O3 nano_A
pigment was supplied by BASF Colors and Effects (Ludwigshafen, Germany). Ag NM300k and
ZnO NM111 were obtained from the JRC nanomaterial repository [18]. Such repository includes
representative industrial NFs studied in large research projects and in the Organization for Economic
Co-operation and Development testing program. Metal salts were provided by EMSURE (ZnCl2
and CuSO4·5H2O, Darmstadt, Germany), Honeywell Fluka (AgNO3, Seelze, Germany) and Merk
(FeSO4·7H2O, Darmstadt, Germany).
The physicochemical properties of Ag NM300k [19] and the other NFs [9] have been previously
reported and are included in the supplementary information (Table S1). The reagents employed during
each reactivity assay were reported in the supplementary information.
2.2. FRAS
In FRAS, antioxidants in human blood serum (HBS) act as “reporters” for quantifying the oxidative
damage induced by NFs [20]. The depletion of the total antioxidants in HBS due to interaction with ROS
produced by NFs is quantified using the Fe-2,4,6-tripyridyl-s-triazine (TPTZ) complex. The method is
based on the reduction of Fe(III)-TPTZ complex to a Fe(II)-TPTZ by residual antioxidant components
present in HBS after NF exposure. A detailed protocol of the assay has been reported elsewhere [21].
In short, the test is divided in three steps: (I) The preincubation of the NFs (0.02–38 g/L) with HBS for
3 h at 37 ◦C, (II) the separation of the NFs from HBS via ultracentrifugation step (AUC-Beckman XL
centrifuge (Brea, CA, USA) at 140,000 G for 150 min) and (III) the transfer of 100 µL of NF-free HBS
supernatant to the FRAS reagent solution that contains the Fe(III)-TPTZ complex. Thus, the UV-vis
spectrum of the iron complex solution is recovered to determine the total antioxidant depletion as
a measure of the oxidative potential of NFs. Trolox, a water-soluble analog of vitamin E, was used
as an antioxidant to calibrate the FRAS results. FRAS protocol was performed at various Trolox
concentration (from 0.001 to 0.1 g/L) for obtaining FRAS absorption signals that can be linearly fitted.
Thus, the oxidative damage induced by NFs was then calculated in Trolox equivalent units (TEUs).
Additionally, fresh NF samples were prepared to evaluate the ion contribution. After an
ultracentrifugation step, the ion concentration in NF-free HBS supernatants was determined by
ICP-MS (Perkin Elmer, Nexion 2000b, Waltham, MA, USA). Using water soluble metal salts (ZnCl2,
CuSO4·5H2O, AgNO3, FeSO4·7H2O), ions solutions with equivalent concentrations were prepared and
the associated oxidative damage in HBS was measured by FRAS method. For each NF and ions dose,
triplicate measurements were performed.
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2.3. EPR
EPR spectroscopy was employed to detect hydroxyl radicals (•OH) using a DMPO spin trap.
Applying the standard ISO TS18827:2017, measurements were performed on a Bruker EMXnano (CW,
X-band, Elk Grove Village, IL, USA) incubating CuO NFs (1–4000 mg/L) for 30 min in deionized water
containing 50 mM DMPO, 0.001 mM FeSO4, and 0.01 mM H2O2. Table S2 in the supplementary reports
the list of key parameters used during the analysis.
Once CuO reactivity was determined, another solution of CuO was prepared, incubated,
and centrifuged (Heraeus Sepatech centrifuge, Dreieich, Germany) at 5600 G for 10 min. ICP-MS was
used to determine the Cu ion concentration in the supernatant. A solution of CuSO4 with equivalent
Cu concentration was prepared and measured with EPR spectroscopy to determine ion reactivity.
2.4. DCFH2-DA
To determine the contribution of Cu ions to the oxidation of the 2′-7′-dichlorodihydrofluorescin
diacetate (DCFH2-DA) probe, first the DCFH2-DA assay was performed with use of particles only.
DCFH2-DA was prepared by an initial step of chemical hydrolysis of DCFH2 to DCFH-DA in 0.01 M
NaOH. Once neutralized, DCFH2-DA was diluted to 10 µM in phosphate-buffered saline (PBS).
CuO NFs were suspended in phenol red-free minimum essential medium (MEM) with 2% FCS at a
concentration of 1 g/L. This stock was sonicated for 15 min in an ultra-sonicating water bath prior
to serial dilution. Each treatment was added, in triplicate, at a volume of 25 µL to a 96-well plate,
followed by the addition of 225 µL of the 10 µM DCFH2-DA reagent, giving a final CuO concentration
of 1.6, 3.1, 6.3, 12.5, 25, 50, 100 mg/L. Fluorescence intensity was measured at 485/530 ex/em after
incubation at 37 ◦C for 0, 30, 60, and 90 min. The data presented is of measurements at either 30 or
90 min minus measurement at 0 min.
Once these data were collected, two samples were prepared to represent the ionic fraction released
from CuO NFs during the course of the DCFH2-DA assay. These samples represent the onset of
reactivity at EC20 (low dose) and the maximum CuO NF (high dose) concentration used. The onset
of reactivity was determined to be 0.013 g/L (final concentration), and maximum concentration was
0.1 g/L (final concentration). These CuO NF concentrations were suspended and handled as per the
protocol described above, using two incubation times of 90 and 30 min. Each sample was subsequently
centrifuged at 75,000 G for 30 min and the supernatant was removed for Cu quantification by ICP-OES.
At 90 min, the equivalent to 2.5 mg/L was released from the low dose, and 7.0 mg/L from the high
dose; at 30 min, 1.7 and 5.9 mg/L were released from the low and high dose, respectively. Using
corresponding copper concentrations from copper sulphate (CuSO4·5H2O), the DCFH2-DA assay was
performed as before, and data generated from Cu ions were compared to that of CuO NPs.
2.5. Workflow
In this work, we design an experimental stepwise workflow (Figure 1) to determine the possible
contribution of ion to the overall NF oxidative potential. First, the dose-reactivity in response to the NF
is measured. Within this dose range, the concentration of NF which induces the onset of a response (e.g.,
at ~20% of the maximum damage) is established, and is used to determine the concentration of released
ions at the end of the incubation time, using sensitive analytical methods (e.g., ICPMS, ICP-OES).
A soluble salt is then used in place of the NF, at an identical metal ion concentration. It should be
noted that this approach delivers a high bolus concentration of ions at the start of the reactivity assay,
and does not exactly replicate the kinetic release of ions throughout the assay. The complete assay is
performed to determine the reactivity of these ions. With a comparison of the ion response to that of
the original NF response, one can classify this NF and attribute its oxidative potential to either the
particle itself, only the released ions, or a combination of the two.
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3. Results and Discussion
3.1. Concept of Reactivity Classes and Workflow
Considering the dissolution behavior of NFs in an aqueous medium, it is possible to assign NFs
to classes based on the kinetics of dissolution, the reactivity of the NF in a specific reactivity assay,
and the dissolution product(s), which are in most cases ions. For the specific case of closed batch
systems, the thermodynamically driven force for dissolution will gradually decrease, resulting in a
specific steady-state concentration of ions in suspension that will be dependent on the initial particle
concentration. Hence, the ratio of particles-to-dissolution products at steady state will depend on the
initial particle concentration.
The implications of these considerations are that the reactivity of a NF suspension, as measured in
a specific reactivity assay, will depend on the initial particle concentration, the reactivity of the particles,
the reactivity of the ions formed, and the rate of dissolution of the NF as affected by particle size and
particle composition. Through consideration of dissolution kinetics and of the additive reactivity of
particles and ions, we distinguish three classes of (partially or fully) soluble spherical NFs:
(A) Soluble NFs, for which suspension reactivity is determined by particle reactivity, either because
the ions released are less reactive than the NF or because ion release kinetics are slow or because
the solubility limit is below the ion effect threshold.
(a) Most literature shows that a reduced toxicity of ions as compared to particle toxicity is the
exception rather than the rule [22].
(b) Examples include spherical SiO2 at pH above 6.
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(B) Soluble NFs, for which both particles and ions contribute significantly to reactivity, depending on
medium and exposure duration. Read-across of NFs is possible only after detailed analysis of
rates of dissolution as well as information on the reactivity of NFs and ions.
(a) Ag-particles in a system with apparent equilibration of ion release.
(C) Soluble NFs, for which suspension reactivity can be quantified by read-across using ion reactivity.
This can be the consequence of two options: (I) The case in which reactivity of ions and particles is
similar; (II) the case in which the concentration of released ions strongly exceeds the concentration
of particles, whilst this does not discount by the possibility of the particles being far more reactive
than the ions, the rate of dissolution is such that the ions are considered the primary source
of reactivity.
(a) Examples with regard to toxicity include Pb-based perovskites (very high rates of
dissolution) and ZnO-nanoparticles of different size and shape (time-dependent kinetics,
but in general toxicity of Zn-ions and Zn NFs similar).
Following the stepwise workflow (Figure 1), one can determine the contribution of inadvertently
generated ions to the oxidative potential measured from an NF in suspension.
If the particles dominate the reactivity against the ions, then the NF belongs to class A. Surface
reactivity in this class is advised as a key property to assess the biological similarity of different NFs of
the same substance.
When both particle and ions contribute significantly to the oxidative potential of the NF, the sample
belongs to class B; both dissolution in the biological compartment and surface reactivity need to be
considered in comparing NFs.
On the contrary, if the ions from the salt generate an assay response which, suggests that the ions
predominantly determine the reactivity of the NF, the NF belongs to class C. In this case, the dissolution
is the most important property to substantiate similarity between different NFs, whereas the reactivity
assay is less relevant to compare NFs.
Additionally, one may assess the ion concentration at several NF doses. If saturating, the solubility
limit is reached for the specific medium and incubation time, and this may help to understand which
part of the dose-response curve marks the onset of particle surface reactivity in addition to ion reactivity.
3.2. Implementation of Workflow on Different NFs in One Assay
We tested our concept and workflow in two scenarios. Firstly, the workflow was implemented
with one assay (FRAS) to identify the class of four NFs (CuO, ZnO NM110, Fe2O3 nano_A, Ag NM300k).
Secondly, we challenged the consistency of our classification by comparing three assays (FRAS, EPR,
DCFH2-DA) with one NF (CuO).
Figure 2 and Table 1 show the results of workflow implementation with FRAS for all NFs. For each
sample, a dose-response was carried out and one concentration close to ~20% of maximum NF oxidative
potential was selected for further evaluation. CuO was the first NF tested (Figure 2A). After incubation
of the CuO NF in the FRAS assay buffer/media for the duration of the assay at a concentration of 0.27 g/L
(~20% of the measured CuO oxidative potential), the actual Cu ion concentration was determined:
0.017 mg/L. Only a fraction of 0.006% of the dosed particle mass was found in ionic form. Due to FRAS
set-up limitations, the lowest concentration of Cu ion measurable was 1.5 mg/L, which is 2 orders
of magnitude higher than the real ion concentration. Despite the overestimation, the ion oxidative
potential was four times lower (7510 nmol TEU/L) than the response induced by the total CuO NF
(30497 nmol TEU/L). The reactivity of CuO at 0.27 g/L was predominately assigned to the particle with
a steep dose-response curve. Such curve displayed an exponential trend in the first part of the curve as
demonstrated by the fitting equation in the graph. Accordingly, CuO in FRAS belongs to class A.
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Figure 2. Workflow implementation with FRAS testing (A) CuO, (B) ZnO NM110, (C) Fe2O3 nano_A,
and (D) Ag NM300k. All curves represent dose-response data of particles (black, grey) and of ions
(blue, green). TEU, Trolox equivalent unit (mM).
The ion contribution on ZnO NM110 was tested at t o concentrations (Figure 2B), relevant to
the following particle conce tratio s: 0.77 g/L (low dose close to onset of reactivity) and 38.8 g/L
(high dose). At low NF concentration, the workflow r v aled that ZnO NM110 reactivity at low dose
originated completely from the ions, whose response s F dose-response. At a high
NF concentration of 38. g/L, we found contribution of d ions. Since the test reached
the solubility limit, the conc of Zn ions id not change in the two conditions: 200 mg/L
(low dose: 0.77 g/L ZnO) and 280 mg/L (high dose: 38.8 g/L ZnO). Depending of NF dose tested,
ZnO NM110 in FRAS can be assigned to class C (low dose) or class B (high dose). Compared to
expected physiological concentration, class C is relevant for the in vivo reactivity extrapolation.
For Fe2O3 nano_A, the FRAS assay presented significant reactivity with a steep dose-response
with exponential trend (Figure 2C). Fe ion release was negligible with only 0.04% of dissolution and
did not significantly affect the ferric reduction ability of serum. Thus, Fe2O3 in FRAS belongs to class
A because the reactivity is fully attributed to particles.
Finally, the workflow was also implemented for Ag NM300k. The dose-response curve displayed
an artefact of apparent negative Ag NM300k reactivity up to 1 g/L (Figure 2D). As reported in the
literature [20,23], using high NF doses (1–10 g/L) is advisable to avoid false negatives. Our results can
be raised by the reactive dissolution pathway of Ag NFs (Ag0→ Ag+ + e−). However, only 0.2% of
total Ag NM300k amount was dissolved. Considering that Ag ions displayed negligible contribution
to reactivity, Ag NM300k in FRAS was class A.
These four examples demonstrate that the workflow makes the classes of the concept applicable
to experimental results in a pragmatic manner.
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Table 1. Summary of reactivity data for NFs and related ions in the three assays.
NF Assay NF Conc.(g/L)
Total Assay
Reactivity
Ion Conc.
(mg/L)
Ion Release (%
of Total Cu
Content)
Ion Contribution
to Reactivity in
Relation to Particle
Response
Class
CuO
FRAS 0.27 30,497 ± 1910 nmolTEU/L 0.017 0.006 <<25% * A
EPR 2.0 8.45 × 1013 Spin
count
0.46 0.023 7.8% A
DCFH2-DA
(90 min)
12.5 × 10−3 364 ± 32 AU 2.5 24.9 127% C
100 × 10−3 1168 ± 58 AU 7.0 8.8 111% C
DCFH2-DA
(30 min)
12.5 × 10−3 92 ± 5 AU 1.7 16.7 93% C
100 × 10−3 282 ± 47 AU 5.9 7.4 54% B
ZnO
NM110
FRAS
0.77 33,252 ± 6470 nmolTEU/L 200 26 92% C
38.8 109,075 ± 5297 nmolTEU/L 280 0.72 25% B
Fe2O3
nano_A 9.4
41,141 ± 426 nmol
TEU/L 3.3 0.035 16% A
Ag
NM300k 34.6
153,010 ± 24,221
nmol TEU/L 74 0.21 n.a. A
* The oxidative potential of Cu ions (1.5 mg/L) measures 7510 nmol TEU/L.; TEU, Trolox equivalent unit (mM); AU,
arbitrary unit.
3.3. Implementation of Workflow on One NF in Different Assays
In the second scenario, we focused on one NF (CuO). We compared the outcome of FRAS with the
other two assays (EPR, DCFH2-DA) to test the consistency of CuO classification.
The dose-response curve of EPR was steep, and reached saturation at 0.2 g/L (Figure 3B), similar
to saturation in FRAS at 0.5 g/L (Figure 3A). The ion release, evaluated at high CuO dose (2 g/L),
was determined to be low (0.46 mg/L), showing an ion-to-particle ratio comparable to FRAS assay.
In such conditions CuO NFs concentration is 4 orders of magnitude higher than Cu ions alone.
Consequently, Cu ions only weakly promoted the EPR:DMPO-OH signals and CuO was classified as A.
Lastly, the contribution of Cu ions in DCFH2-DA oxidation, in comparison to CuO NPs, was tested
(Figure 3C,D) at two NF concentrations: 12.9 mg/L (low dose = EC20) and 100 mg/L (high dose
= maximum particle concentration used), and two different time points: 90 min (Figure 3C) and
30 min (Figure 3D). Unlike FRAS and EPR, Cu ions substantially contributed to NF reactivity in the
DCFH2-DA assay at both concentrations. At the latter time point, the oxidation of DCFH appears to
be driven by released Cu ions; at the earlier time point, this is also true for the low dose, however,
at the high dose, it appeared both particles and ions contribute. A key difference is the dose range:
the DCFH2-DA abiotic assay, often conducted in parallel to the use of DCFH2-DA in cell exposures,
is usually performed at the low concentrations that are admissible to cell cultures: mg/L instead of the
g/L used in the strictly abiotic EPR and FRAS methods. Hence, according to solubility limit, the share
of particles that dissolve is higher in DCFH2-DA. In DCFH2-DA analysis of CuO, the ion-to-particle
ratio (25% and 9% after 90 min, and 17% and 7% at 30 min) is 3 orders of magnitudes higher than in
FRAS and EPR tests. But that is not the only difference: The CuO dose-response curve in DCFH2-DA
has negative curvature at lower concentrations and display a linear trend as concentrations increase up
to 0.1 g/L, whereas it has positive and exponential curvature (onset of particle reactivity) in EPR and
FRAS at higher dose. CuO in DCFH2-DA was assigned to class C in most cases, because the Cu ion
release is the main contributor to CuO reactivity, and to class B at high particle concentration (relative
to assay restrictions) at early time points.
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30 min for DCFH2-DA respectively, but 10 min for EPR. However, there is evidence that Cu ions are 
generated during the test and have a strong contribution to the oxidation of DCFH2-DA. As it was 
thought plausible that the differences in effects observed between these three assays were due to the 
observations of low (FRAS, EPR) or high (DCFH2-DA) ion release in different medium, as opposed 
to differences in the way each assay interacts with particles and/or ions. As reported in the 
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to ions if present.  
In summary of measuring CuO in the three reactivity assays, the classification was not 
unequivocal. FRAS and EPR classified CuO as A, where the reactivity is determined by particles. 
Instead, DCFH2-DA demonstrated a strong ion contribution, mostly categorizing CuO as class C.  
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DCFH2-DA buffer leads to higher CuO dissolution than the EPR and FRAS ones, and (III) assays may 
Figure 3. Workflow implementa ion with FRAS (A), EPR (B), DCFH2-DA (C,D) testing CuO NF and ion
reactivity. All curves repr sent dose-response data of particles (black, grey) and of ions concentrati
(blue, green). TEU, Trolox equivalent unit (mM); AU, arbitrary unit.
Nevertheless, it is important to highlight that the determination of the ion concentration at the
end of incubation results in an extension of the contact time between the particles and the fluid and
this, in combination with using a bolus dose of metal ions, may increase the release of ions with
regards to correct ion concentration. Hence, the workflow may overestimate the contribution of ions
during the NF incubations in FRAS and DCFH2-DA. The separation time was 150 min for FRAS and
30 min for DCFH2-DA respectively, but 10 min for EPR. However, there is evidence that Cu ions are
generated during the test and have a strong contribution to the oxidation of DCFH2-DA. As it was
thought plausible that the differences in effects observed between these three assays were due to the
observations of low (FRAS, EPR) or high (DCFH2-DA) ion release in different medium, as opposed to
differences in the way each assay interacts with particles and/or ions. As reported in the supplementary
information (Figure S1), we have shown that FRAS would also have a high sensitivity to ions if present.
In summary of measuring CuO in the three reactivity assays, the classification was not unequivocal.
FRAS and EPR classified CuO as A, where the reactivity is determined by particles. Instead, DCFH2-DA
demonstrated a strong ion contribution, mostly categorizing CuO as class C.
This outcome can be elucidated taking in consideration three main factors: (I) Diverse assays
analyzed different NF dose concentration (from mg/L to g/L), because the probability that the particle
surfaces contribute to reactivity is higher if tested at a concentration above the solubility limit, (II) the
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DCFH2-DA buffer leads to higher CuO dissolution than the EPR and FRAS ones, and (III) assays
may display different sensitivity to ions or particles. As results, DCFH2-DA assay seems to be
especially dominated by Cu ions, whereas the FRAS assay is sensitive to Cu ions, but still dominated
by particle-induced reactivity. In comparison to ZnO in FRAS, the classes B or C apply depending on
the dose tested. The literature to ZnO and CuO has often tried to assign the nanomaterial to either class
A, B, or C, but our results caution such assignment to material properties, and instead recommend an
assignment for the combination of assay (incl. medium, dose range etc.) and material.
4. Conclusions
In this work, we present a practical workflow to determine the contribution to reactivity by
particle surfaces and by ions that are inadvertently generated during incubation of NFs in an aquatic
medium. Up till now, it has been overlooked that NFs as well as ions contribute to the outcome of
reactivity assays. The workflow that we present is new as it for the first time allows the contribution of
NFs and ions to reactivity to be quantified. Amongst others, the underlying concept of separation of
the contributions of NFs and ions is broadly applicable to any reactivity assay as well as to, for instance,
toxicity assessment of aquatic suspensions of NFs.
We find that the “relative” toxicity of ions and particles may be a misleading concept. Because the
incubation phases of assays differ with regard to medium, concentration, and duration, the DCFH2-DA,
EPR, FRAS assays are performed under different ion-to-particle ratios. Additionally, the assays differ in
their sensitivity towards reactions induced by either ions or particles. Taken together, the dose-response
to CuO nanoparticles may be assigned mostly to ions in one assay (DCFH2-DA), but almost entirely to
particles in another (FRAS).
If applied for grouping, read-across, or other concepts based on the similarity of NFs, results
on reactivity should only be compared if measured by the same assay, incubation time, and dose
range. For the specific case of ZnO in FRAS and for CuO in DCFH2-DA, the reactivity at doses up to
100 µg/mL is mostly assigned to the ions. For these materials, similarity of dissolution kinetics may be
more important to compare different NFs of the same substance than testing their reactivity.
Supplementary Materials: The following are available online at http://www.mdpi.com/1996-1944/13/10/2235/s1.
Figure S1: FRAS dose-dependent results for Cu ions, Table S1: Main physicochemical characteristics of NFs,
Table S2: The list of key parameters employed during EPR measurements.
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